Samuel T Gong, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 1
- 1 carrier
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: Marian Regional Medical Center. That is not proof they admit you there this week.
Plans that list them
1 plan · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Gong’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A176710 · Current
Licensed to practise in California · since 2022 · expires 2028-05-31 · Drexel University College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Marian Regional Medical CenterSanta Maria, CAAcute Care Hospital · Voluntary non-profit - Church · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — CMS Medicare PSI 90: Patient safety and adverse events composite: 0.67 (0.37 to 0.96), Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.081, Oct 2024 – Sep 2025
See every measure and the patient survey for Marian Regional Medical Center
Behind the star rating — Deaths: 0 better, 7 the same, 1 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.67 (0.37 to 0.96) | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.081 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.99 (0.06 to 1.93) · 1,191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 189.73 (139.29 to 240.17) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 3.7 · 103 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 15.9 · 247 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.7 · 478 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.4 · 470 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.5 · 237 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 3,050 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.14 (0 to 0.34) · 8,823 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.24 (0.05 to 0.42) · 8,672 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.87 (0.97 to 4.76) · 2,024 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.12 (0.57 to 3.67) · 782 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.29 (0.85 to 3.72) · 1,934 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 3.63 (0 to 9.97) · 787 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.01 (1.37 to 8.65) · 748 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.88 (0.43 to 3.32) · 373 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.13 (0 to 0.73) · 6,968 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 179 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.245 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.85 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.952 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.687 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.5 · 198 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.6 · 469 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.8 · 232 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -9.8 · 541 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8.6 · 473 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.8 · 434 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.6 (5 to 8.4) · 519 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.9 (8.8 to 13.4) · 519 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.2 · 152 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.3 · 83 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.2 to 17) · 124 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.9 to 1.4) · 638 cases | No different | Jan 2024 – Dec 2024 |
What patients said (666 patients answered, 17% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 64% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 79% |
| Nurses "always" explained things so they could understand | 76% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$127,642
Medicare paid this office $127,642 for 347 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 288 | $52,650 | $93 |
| Long return visit (40+ min) | 135 | $29,076 | $137 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 39 | $11,290 | $289 |
| Short return visit (20+ min) | 90 | $7,768 | $72 |
| Influenza vaccine, inactivated | 58 | $4,827 | $82 |
See all 16 services
| Return visit (30+ min) | 288 | $52,650 | $93 |
| Long return visit (40+ min) | 135 | $29,076 | $137 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 39 | $11,290 | $289 |
| Short return visit (20+ min) | 90 | $7,768 | $72 |
| Influenza vaccine, inactivated | 58 | $4,827 | $82 |
| New patient visit (45+ min) | 37 | $3,595 | $97 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 199 | $3,558 | $14 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 19 | $2,776 | $146 |
| Administration of influenza virus vaccine | 62 | $2,156 | $34 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 25 | $1,365 | $47 |
| Administration of pneumococcal vaccine | 39 | $1,335 | $34 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 22 | $619 | $25 |
| Assessment of emotional or behavioral problems | 93 | $501 | $4 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $311 | $12 |
| Hemoglobin a1c level | 16 | $190 | $10 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $38 | None |
Procedures Medicare counted
| Removal or shaving of skin growth | 1-10 | None |
Who their Medicare patients are
347 Original Medicare patients in 2024. Average age 73 · Under 65 8% · 85 and older 11% · Women 56% · Also on Medicaid 25% · Health risk score 1.06. At or below the middle of the specialty; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 26% · Chronic kidney disease 22% · Depression 20% · Coronary heart disease 17% · Cancer 15% · Atrial fibrillation 14% · Heart failure 10% · COPD 10% · Dementia 9% · Stroke 7%.
The office billed $351,942, Medicare allowed $177,413 and paid $127,642; for 1,904 services of 56 kinds; $16,413 of it was for drugs given in the office and $111,229 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 347 | 1,904 | 73 | 1.06 | $351,942 | $127,642 |
| 2023 | 268 | 1,075 | 72 | 1.06 | $249,279 | $94,154 |
| 2022 | 40 | 106 | 73 | 0.64 | $22,365 | $9,764 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 13 services
| Return visit (30+ min) | 217 | $47,010 | $100 |
| Long return visit (40+ min) | 62 | $11,914 | $145 |
| Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 40 | $11,268 | $282 |
| New patient visit (45+ min) | 84 | $8,694 | $103 |
| Short return visit (20+ min) | 54 | $3,939 | $67 |
| Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | 35 | $2,648 | $76 |
| Administration of pneumococcal vaccine | 40 | $1,316 | $33 |
| Administration of influenza virus vaccine | 37 | $1,217 | $33 |
| Hemoglobin a1c level | 21 | $219 | $10 |
| Assessment of emotional or behavioral problems | 32 | $164 | $4 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 14 | $137 | $10 |
| Blood glucose (sugar) test performed by hand-held instrument | 13 | $45 | $3 |
| Urinalysis, manual test | 11 | $41 | $3 |
2022: 2 services
| Return visit (30+ min) | 28 | $5,351 | $105 |
| New patient visit (45+ min) | 16 | $1,960 | $123 |
Medicaid work
$7,084 in 2024
Medicaid paid $7,084 for 2,049 billed services this clinician did in 2024, up to 49 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 258 | $4,657 |
| Long return visit (40+ min) | 71 | $1,865 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 12 | $250 |
| Service | 1,044 | $237 |
| Service | 207 | $29 |
| COMPREHENSIVE METABOLIC PANEL | 31 | $23 |
| Service | 250 | $14 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 26 | $9 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 60 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 32 | $0 |
| COLLECTION VENOUS BLOOD VENIPUNCTURE | 34 | $0 |
| Blood test, lipids (cholesterol and triglycerides) | 24 | $0 |
| 2024 | 2,049 | 12 | 49 | $7,084 |
| 2023 | 1,577 | 9 | 55 | $12,768 |
| 2022 | 35 | 2 | 19 | $1,786 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 454 | $10,414 |
| New patient visit (45+ min) | 14 | $1,024 |
| Service | 792 | $447 |
| Long return visit (40+ min) | 15 | $332 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 13 | $269 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 12 | $241 |
| Service | 84 | $31 |
| Service | 181 | $10 |
| Screening for depression is documented as negative, a follow-up plan is not required | 12 | $0 |
2022
| Return visit (30+ min) | 23 | $1,639 |
| Screening for depression is documented as negative, a follow-up plan is not required | 12 | $146 |
Drugs they prescribed that Part D paid
$416,453
Pharmacies billed $416,453 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (34 of 4,074) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
3,548 generic and fewer than 11 brand-name prescriptions · $416,453 in drug cost · 41 antibiotic prescriptions to 30 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 32 | $49,564 | $1,549 |
| Kerendia | 21 | $31,632 | $1,506 |
| Jardiance | 28 | $27,302 | $975 |
| Ozempic | 29 | $27,005 | $931 |
| Xigduo Xr | 20 | $21,545 | $1,077 |
See all 85 drugs
| Eliquis | 32 | $49,564 | $1,549 |
| Kerendia | 21 | $31,632 | $1,506 |
| Jardiance | 28 | $27,302 | $975 |
| Ozempic | 29 | $27,005 | $931 |
| Xigduo Xr | 20 | $21,545 | $1,077 |
| Farxiga | 18 | $20,193 | $1,122 |
| Trelegy Ellipta | 20 | $17,556 | $878 |
| Xarelto | 16 | $14,877 | $930 |
| Combivent Respimat | 13 | $6,055 | $466 |
| Tresiba Flextouch U-200 | 11 | $4,780 | $435 |
| Belsomra | 11 | $4,652 | $423 |
| Fluticasone-Salmeterol | 14 | $4,399 | $314 |
| Rosuvastatin | 165 | $3,999 | $24 |
| Albuterol Sulfate Hfa | 71 | $2,849 | $40 |
| Telmisartan | 55 | $2,256 | $41 |
| Dabigatran Etexilate | 13 | $2,201 | $169 |
| Gabapentin | 105 | $2,067 | $20 |
| Levothyroxine | 151 | $1,986 | $13 |
| Duloxetine | 48 | $1,690 | $35 |
| Atorvastatin | 223 | $1,684 | $8 |
| Ezetimibe | 23 | $1,234 | $54 |
| Fluticasone Propionate | 86 | $1,171 | $14 |
| Amlodipine Besylate | 169 | $1,170 | $7 |
| Ziprasidone | 13 | $1,157 | $89 |
| Tamsulosin | 73 | $1,122 | $15 |
| Hydroxyzine | 44 | $1,099 | $25 |
| Olmesartan Medoxomil | 41 | $1,098 | $27 |
| Valsartan | 37 | $1,008 | $27 |
| Losartan | 105 | $959 | $9 |
| Omeprazole | 67 | $930 | $14 |
| Trazodone | 99 | $927 | $9 |
| Solifenacin | 11 | $925 | $84 |
| Lisinopril | 119 | $792 | $7 |
| Doxepin | 16 | $741 | $46 |
| Diclofenac | 41 | $722 | $18 |
| Pravastatin | 35 | $598 | $17 |
| Metoprolol | 47 | $596 | $13 |
| Alendronate | 73 | $552 | $8 |
| Ketoconazole | 28 | $542 | $19 |
| Bupropion Xl | 12 | $500 | $42 |
| Montelukast | 34 | $484 | $14 |
| Pantoprazole | 35 | $470 | $13 |
| Donepezil | 19 | $452 | $24 |
| Potassium Chloride | 29 | $432 | $15 |
| Clomipramine | 13 | $403 | $31 |
| Triamcinolone Acetonide | 50 | $403 | $8 |
| Metoprolol | 49 | $401 | $8 |
| Allopurinol | 38 | $393 | $10 |
| Propranolol | 20 | $384 | $19 |
| Nabumetone | 34 | $359 | $11 |
| Carvedilol | 37 | $349 | $9 |
| Tizanidine | 27 | $338 | $13 |
| Metformin | 51 | $330 | $6 |
| Metformin Hcl Er | 38 | $321 | $8 |
| Simvastatin | 29 | $317 | $11 |
| Pregabalin | 19 | $308 | $16 |
| Venlafaxine Hcl Er | 19 | $300 | $16 |
| Escitalopram | 30 | $284 | $9 |
| Ondansetron Odt | 21 | $262 | $12 |
| Chlorthalidone | 16 | $234 | $15 |
| Enalapril Maleate | 11 | $231 | $21 |
| Fluoxetine | 22 | $224 | $10 |
| Amitriptyline | 27 | $214 | $8 |
| Hydrochlorothiazide | 62 | $213 | $3 |
| Clopidogrel | 21 | $202 | $10 |
| Finasteride | 21 | $194 | $9 |
| Terbinafine | 30 | $192 | $6 |
| Sertraline | 27 | $188 | $7 |
| Furosemide | 57 | $185 | $3 |
| Baclofen | 20 | $181 | $9 |
| Hydralazine | 12 | $159 | $13 |
| Famotidine | 13 | $149 | $11 |
| Dicyclomine | 11 | $138 | $13 |
| Atenolol | 18 | $119 | $7 |
| Zolpidem | 26 | $111 | $4 |
| Sumatriptan | 16 | $109 | $7 |
| Mupirocin | 13 | $107 | $8 |
| Benazepril | 15 | $105 | $7 |
| Citalopram Hbr | 34 | $94 | $3 |
| Naproxen | 19 | $82 | $4 |
| Lamotrigine | 15 | $77 | $5 |
| Tramadol | 16 | $67 | $4 |
| Ibuprofen | 12 | $52 | $4 |
| Meloxicam | 33 | $35 | $1 |
| Sulfamethoxazole-Trimethoprim | 11 | $17 | $2 |
Year by year
| 2024 | 4,074 | 319 | 1% (34) | None | $416,453 |
| 2023 | 2,051 | 240 | 1% (18) | None | $272,259 |
| 2022 | 794 | 97 | None | None | $111,073 |
| 2021 | 635 | 73 | None | None | $80,961 |
| 2020 | 212 | 55 | None | None | $11,707 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 51 drugs
| Eliquis | 34 | $50,988 | $1,500 |
| Jardiance | 27 | $28,884 | $1,070 |
| Trelegy Ellipta | 16 | $14,035 | $877 |
| Ozempic | 12 | $13,892 | $1,158 |
| Kerendia | 11 | $11,521 | $1,047 |
| Combivent Respimat | 12 | $5,453 | $454 |
| Olmesartan Medoxomil | 52 | $2,260 | $43 |
| Gabapentin | 83 | $2,007 | $24 |
| Diclofenac | 47 | $1,616 | $34 |
| Rosuvastatin | 53 | $1,531 | $29 |
| Telmisartan | 29 | $1,476 | $51 |
| Duloxetine | 20 | $1,322 | $66 |
| Levothyroxine | 63 | $1,271 | $20 |
| Atorvastatin | 78 | $1,118 | $14 |
| Valsartan | 24 | $1,058 | $44 |
| Alendronate | 50 | $936 | $19 |
| Fluticasone Propionate | 42 | $924 | $22 |
| Celecoxib | 12 | $923 | $77 |
| Tamsulosin | 38 | $908 | $24 |
| Lisinopril | 54 | $856 | $16 |
| Metoprolol | 39 | $753 | $19 |
| Amlodipine Besylate | 78 | $746 | $10 |
| Albuterol Sulfate Hfa | 22 | $680 | $31 |
| Trazodone | 49 | $659 | $13 |
| Oxybutynin Chloride Er | 16 | $641 | $40 |
| Omeprazole | 33 | $629 | $19 |
| Losartan | 41 | $569 | $14 |
| Escitalopram | 20 | $568 | $28 |
| Hydroxyzine | 17 | $554 | $33 |
| Pravastatin | 20 | $480 | $24 |
| Metformin | 22 | $391 | $18 |
| Finasteride | 15 | $363 | $24 |
| Montelukast | 22 | $318 | $14 |
| Nabumetone | 24 | $290 | $12 |
| Potassium Chloride | 13 | $273 | $21 |
| Ketoconazole | 11 | $247 | $22 |
| Carvedilol | 14 | $247 | $18 |
| Allopurinol | 20 | $245 | $12 |
| Metformin Hcl Er | 25 | $236 | $9 |
| Metoprolol | 21 | $235 | $11 |
| Sertraline | 11 | $211 | $19 |
| Chlorthalidone | 14 | $206 | $15 |
| Triamcinolone Acetonide | 25 | $201 | $8 |
| Pantoprazole | 11 | $201 | $18 |
| Furosemide | 35 | $181 | $5 |
| Simvastatin | 15 | $168 | $11 |
| Citalopram Hbr | 17 | $151 | $9 |
| Tramadol | 12 | $124 | $10 |
| Hydrochlorothiazide | 21 | $103 | $5 |
| Sulfamethoxazole-Trimethoprim | 18 | $79 | $4 |
| Clonidine | 11 | $25 | $2 |
2022: 24 drugs
| Eliquis | 14 | $12,683 | $906 |
| Xarelto | 12 | $12,025 | $1,002 |
| Breo Ellipta | 19 | $11,919 | $627 |
| Spiriva Handihaler | 12 | $9,620 | $802 |
| Symbicort | 12 | $4,885 | $407 |
| Ventolin Hfa | 17 | $1,284 | $76 |
| Gabapentin | 32 | $816 | $26 |
| Levothyroxine | 27 | $514 | $19 |
| Oxybutynin Chloride Er | 22 | $480 | $22 |
| Albuterol Sulfate Hfa | 14 | $440 | $31 |
| Atorvastatin | 46 | $427 | $9 |
| Omeprazole | 18 | $311 | $17 |
| Losartan | 18 | $173 | $10 |
| Phenytoin Sodium Extended | 12 | $159 | $13 |
| Metformin | 17 | $128 | $8 |
| Pantoprazole | 11 | $106 | $10 |
| Lisinopril | 17 | $106 | $6 |
| Amlodipine Besylate | 11 | $91 | $8 |
| Metoprolol | 13 | $88 | $7 |
| Cyclobenzaprine | 11 | $83 | $8 |
| Furosemide | 18 | $55 | $3 |
| Zolpidem | 12 | $35 | $3 |
| Sulfamethoxazole-Trimethoprim | 15 | $22 | $1 |
| Citalopram Hbr | 14 | $19 | $1 |
2021: 21 drugs
| Spiriva | 11 | $12,680 | $1,153 |
| Xarelto | 12 | $11,427 | $952 |
| Eliquis | 12 | $10,236 | $853 |
| Trelegy Ellipta | 11 | $6,957 | $632 |
| Ec-Naproxen | 13 | $2,635 | $203 |
| Ventolin Hfa | 19 | $1,110 | $58 |
| Atorvastatin | 34 | $638 | $19 |
| Albuterol Sulfate Hfa | 16 | $559 | $35 |
| Tamsulosin | 16 | $439 | $27 |
| Gabapentin | 21 | $421 | $20 |
| Finasteride | 12 | $287 | $24 |
| Lisinopril | 28 | $242 | $9 |
| Omeprazole | 12 | $210 | $17 |
| Metformin | 23 | $143 | $6 |
| Sertraline | 12 | $142 | $12 |
| Metoprolol | 11 | $141 | $13 |
| Ondansetron Odt | 12 | $104 | $9 |
| Zolpidem | 13 | $92 | $7 |
| Prednisone | 13 | $66 | $5 |
| Meloxicam | 11 | $56 | $5 |
| Amlodipine Besylate | 11 | $45 | $4 |
2020: 2 drugs
| Atorvastatin | 17 | $140 | $8 |
| Amlodipine Besylate | 12 | $57 | $5 |
Money from drug and device companies
$15 in 2025
| 2025 | 1 | 1 | None | $15 |
| 2024 | 14 | 54 | None | $1,057 |
| 2023 | 14 | 106 | None | $1,714 |
| 2022 | 6 | 13 | None | $237 |
| 2021 | 1 | 1 | None | $14 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Pfizer | Prevnar 20 | $15 | 1 payment
|
See the published payment
| Pfizer | Meals · 2025-01-24 | Prevnar 20 | $15 |
See earlier years (2024, 2023, 2022, 2021)
2024: $1,057
| Novo Nordisk | Ozempic | $172 | 11 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $155 | 8 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $123 | 6 payments
|
| Pfizer | Prevnar 20 | $95 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Synjardy | $92 | 4 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $82 | 5 payments
|
| Amgen | Otezla | $77 | 3 payments
|
| Abbvie | Vraylar | $71 | 3 payments
|
| Lilly USA | Mounjaro | $51 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $46 | 2 payments
|
| Mannkind | Afrezza | $29 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $24 | 1 payment
|
| Astellas Pharma US | Veozah | $24 | 1 payment
|
| Bausch Health US | Wellbutrin | $15 | 1 payment
|
2023: $1,714
| Novo Nordisk | Ozempic | $305 | 23 payments
|
| Abbvie | Qulipta | $234 | 14 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $210 | 10 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $194 | 14 payments
|
| Lilly USA | Mounjaro | $189 | 9 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $159 | 8 payments
|
| GlaxoSmithKline | Trelegy Ellipta | $140 | 12 payments
|
| MannKind | Afrezza | $74 | 4 payments
|
| Exact Sciences | Cologuard Collection Kit | $68 | 3 payments
|
| Idorsia Pharmaceuticals US | Quviviq | $42 | 2 payments
|
| Pfizer | Prevnar 20 | $34 | 2 payments
|
| Mylan Specialty L.P. | Yupelri | $23 | 1 payment
|
| Amgen | Otezla | $22 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Trintellix | $19 | 1 payment
|
2022: $237
| Novo Nordisk | Ozempic | $58 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $57 | 3 payments
|
| Lilly USA | Mounjaro | $45 | 3 payments
|
| Abbvie | Qulipta | $32 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Tradjenta | $25 | 1 payment
|
| Pfizer | Prevnar 20 | $20 | 1 payment
|
2021: $14
| Pfizer | Cologuard Dna Capture Reagents | $14 | 1 payment
|
Professional record
- NPI
- 1215496260
- Licence
- CA A176710California A176710: Current · expires 2028-05-31
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2019-03-19
- NPI last updated
- 2025-06-23
- NPI record certified
- 2025-06-23
This is when the NPI record was last certified, not a medical board exam.